Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival

Autor: Anna van der Voort, Marte C. Liefaard, Mette S. van Ramshorst, Erik van Werkhoven, Joyce Sanders, Jelle Wesseling, Astrid Scholten, Marie Jeanne T.F.D. Vrancken Peeters, Linda de Munck, Sabine Siesling, Gabe S. Sonke

Publikováno v: Breast, Vol 65, Iss , Pp 110-115 (2022)

Background: Pathologic complete response (pCR) rates in early stage HER2-positive breast cancer improved after pertuzumab was added to neoadjuvant treatment. However, survival benefit is less-well established and seems mostly limited to node-positive

Externí odkaz: https://doaj.org/article/8afd7b7a51b54354ada4317477a5ee96

European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer

Autor: Icro Meattini, Carlotta Becherini, Liesbeth Boersma, Orit Kaidar-Person, Gustavo Nader Marta, Angel Montero, Birgitte Vrou Offersen, Marianne C Aznar, Claus Belka, Adrian Murray Brunt, Samantha Dicuonzo, Pierfrancesco Franco, Mechthild Krause, Mairead MacKenzie, Tanja Marinko, Livia Marrazzo, Ivica Ratosa, Astrid Scholten, Elżbieta Senkus, Hilary Stobart, Philip Poortmans, Charlotte E Coles

Publikováno v: Meattini, I, Becherini, C, Boersma, L, Kaidar-Person, O, Marta, G N, Montero, A, Offersen, B V, Aznar, M C, Belka, C, Brunt, A M, Dicuonzo, S, Franco, P, Krause, M, MacKenzie, M, Marinko, T, Marrazzo, L, Ratosa, I, Scholten, A, Senkus, E, Stobart, H, Poortmans, P & Coles, C E 2022, ' European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer ', The Lancet Oncology, vol. 23, no. 1, pp. e21-e31 . https://doi.org/10.1016/S1470-2045(21)00539-8
The lancet oncology

High-quality randomised clinical trials testing moderately fractionated breast radiotherapy have clearly shown that local control and survival is at least as effective as with 2 Gy daily fractions with similar or reduced normal tissue toxicity. Fewer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ea048ef2401eb4cedcfb0d53c2f590
https://pure.au.dk/portal/da/publications/european-society-for-radiotherapy-and-oncology-advisory-committee-in-radiation-oncology-practice-consensus-recommendations-on-patient-selection-and-dose-and-fractionation-for-external-beam-radiotherapy-in-early-breast-cancer(8bb4b0f6-32fe-43cd-aff8-861d7bc47073).html

Recognition of Credits in the Framework of Socrates. A Dutch Case Study

Autor: Liduine Bremer, Astrid Scholten

Publikováno v: Journal of Studies in International Education. 3:89-102

The recognition of credits across borders, in particular in theframework of the Socratesprogramme, is the subject of a recent study undertaken by the Netherlands Organization for International Cooperation in Higher Education (Nuffic). This articlepre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1260206ced0a35a884c80372d8bc05f0
https://doi.org/10.1177/102831539900300207